NIFTY 50▲24,834.85
428.75 (1.76%)
SENSEX▲81,332.72
1292.92 (1.62%)
NIFTY BANK▲51,295.95
407.20 (0.80%)
INDIAN RAILWAY FINANCE CORP▼183.44
-0.12 (-0.07%)
TATA MOTORS▲1,118.30
27.35 (2.51%)
TATA STEEL▲162.55
5.16 (3.28%)
TATA POWER▲444.70
21.35 (5.04%)
SUZLON ENERGY▲61.89
0.42 (0.68%)
RAIL VIKAS NIGAM▼552.35
-23.35 (-4.06%)
INDIAN RENEWABLE ENERGY▼258.03
-3.15 (-1.21%)
VODAFONE IDEA▲15.98
0.80 (5.27%)
RELIANCE INDUSTRIES▲3,018.05
33.25 (1.11%)
YES BANK▲24.97
0.35 (1.42%)
ADANI POWER▲712.65
17.45 (2.51%)
NHPC▲104.62
2.66 (2.61%)
STATE BANK OF INDIA▲862.45
13.95 (1.64%)
HDFC BANK▲1,618.15
1.55 (0.10%)
RELIANCE POWER▲29.77
0.08 (0.27%)
JIO FIN SERVICES LTD▲331.90
2.70 (0.82%)
ZOMATO▲224.62
5.31 (2.42%)
ADANI PORT & SEZ▲1,542.75
55.75 (3.75%)
BHARAT ELECTRONICS▲309.90
8.45 (2.80%)
INDIAN RAILWAY TOURISM CORP▲984.15
15.00 (1.55%)
INDIAN OIL CORP▼176.55
-0.30 (-0.17%)
RATTANINDIA POWER▲16.87
0.06 (0.36%)
MRF▲1,38,870.35
1280.25 (0.93%)
ADANI ENTERPRISES▲3,080.50
107.00 (3.60%)
JAIPRAKASH POWER VENTURES▲19.66
0.83 (4.41%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/BSE_EQ|INE947G01011.png)
MERCURY LABORATORIES LIMITED Share Price
MERCURYLAB
₹951.55-₹7.45 (-0.78%) TodayLast updated on 26 Jul, 2024 | 15:29 IST
₹950.00₹994.00
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹994.00 | Close₹959.00 |
Circuit range₹1,046.70 - ₹856.40 | Day range₹950.00 - ₹994.00 | Year range₹709.00 - ₹1,303.00 |
Volume95 | Avg. traded₹959.11 | Revenue (12m)₹76 Crs |
MERCURY LABORATORIES LIMITEDMercury Laboratories Limited is an India-based pharmaceutical company. The Company operates through the Pharmaceuticals Products segment. The Company is engaged in the manufacturing and export of a range of pharmaceutical items. The products of the Company are in the segment of gynecology and pediatrics. Its products include antibiotic, antifungal, and antiviral formulations; anti-inflammatory formulations; antimalarial formulations; digestive formulations; hypoglycemic formulations; multivitamin formulations; central nervous system formulations; gynec formulations; CVS formulations; cough and cold formulations; and miscellaneous formulations, among others. Its antibiotic, antifungal, and antiviral formulations include azithromycin tablets, azithromycin dispersible tablets, griseofulvin tablets, metronidazole tablets, and others. Its anti-inflammatory formulations include dexamethasone tablets, glucosamine sulphate tablets, dexamethasone sodium phosphate injection, and others.
MERCURY LABORATORIES LIMITED Key indicators
52 week high₹1,303.00 | 52 week low₹709.00 | P/E ratio21.67 |
P/B ratio2.25 | ROE12.98% | ROCE16.29% |
Dividend yield0.37% | Debt/Equity ratio0.12 | EPS46.49 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin13.66% | Net profit margin7.41% |
ROE12.98% | ROA8.58% |
ROCE16.29% |
Learn more
MERCURY LABORATORIES LIMITED Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Jul 25 2024 | ₹960.00 | ₹959.00 | -2.33% |
Wed, Jul 24 2024 | ₹995.00 | ₹981.90 | -3.83% |
Tue, Jul 23 2024 | ₹1,021.00 | ₹1,021.00 | |
Mon, Jul 22 2024 | ₹956.60 | ₹1,002.50 | -2.57% |
Fri, Jul 19 2024 | ₹1,039.00 | ₹1,028.90 | |
Thu, Jul 18 2024 | ₹1,032.65 | ₹1,024.00 | -0.84% |
Tue, Jul 16 2024 | ₹1,063.00 | ₹1,032.65 | |
Mon, Jul 15 2024 | ₹1,001.00 | ₹1,002.65 | -0.62% |
Events
Corporate actions
Dividend • ₹3.5/share
Ex date 20 Sep 2024
Dividend • ₹3.5/share
Ex date 20 Sep 2023
Dividend • ₹3.5/share
Ex date 19 Sep 2022
Learn more